Chemistry: molecular biology and microbiology – Kit
Reexamination Certificate
2007-02-27
2007-02-27
Navarro, Mark (Department: 1645)
Chemistry: molecular biology and microbiology
Kit
Reexamination Certificate
active
10418421
ABSTRACT:
A diversity of inflammatory diseases can be treated via local delivery to the patient of a composition containing a therapeutically effective amount of an anti-malarial agent. In a preferred embodiment of the method of the invention, a pulmonary inflammatory condition, such as asthma, is treated by inhalation of an aerosolized anti-malarial agent, such as hydroxychloroquine.
REFERENCES:
patent: 4181725 (1980-01-01), Voorhees et al.
patent: 5716966 (1998-02-01), Cupps et al.
patent: 5773430 (1998-06-01), Simon et al.
patent: 2002/0091139 (2002-07-01), Charous
patent: 6298 (1968-10-01), None
patent: WO 98/17231 (1997-04-01), None
Pontarelli (Delaware Medical Journal vol. 33, pp. 1-3, Jan. 1961).
Barnes, Peter J., “Asthma Therapy with Aerosols: Clinical Relevance for the Next Decade”,Journal of Aerosol Medicine, vol. 9, No. 1, 1996, pp. 131-141.
Busse, William W., et al., “Treatment Regimen and Side Effects of Treatment Measures”,Am. J. Respir. Crit. Care Med., vol. 149, pp. S44-S50, 1994.
Charous, Lauren B., “Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma”,Annals. of Allergy, vol. 65, Jul. 1990, pp. 53-58.
Charous, Lauren B., et al., “Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma”,J. Allergy Clin. Immunol., vol. 102, No. 2, 1998, pp. 198-203.
Charous, Lauren B., “Effectiveness of Long-Term Treatment of Severe Asthma with Hydroxychloroquine (HCQ)”,Annals. of the New York Academy of Sciences, vol. 629, pp. 432-433.
Charous, Lauren B., et al., “Double-blind Trial of Hydroxychloroquine (HCQ) as Anti Allergic Anti-Asthmatic Therapy”,J. Allergy Clin. Immunol., Jan. 1997.
Charous, Lauren B., “Long-Term Treatment of Severe Asthma with Hydroxychloroquine”,Annals of Allergy, vol. 68, No. 1, p. 80, 1992.
Charous, Lauren B., “Double-blind Trial of Hydroxychloroquine (HCQ) As Anti-Allergic Anti-Asthmatic Therapy”,J. Allergy Clin. Immunol., Jan. 1997, p. S268.
Cockcroft, D.W., “Therapy for airway inflammation in asthma”,J. Allergy Clin. Immunol., May 1991, vol. 87, No. 5. pp. 914-919.
Fox, Robert I., et al., “Treatment of Primary Sjogren's Syndrome with Hydroxychloroquine”,The American Journal of Medicine, vol. 85, 1998, p. 62-67.
Goldstein, Jay A., “Hydroxychloroquine for Asthma”,Am. Rev. Res. Diseases, 128(6):1100-1101, 1983.
Landwehr, Lawrence P., et al., “Management of Steroid-Resistant Asthma”,Clin. Immunother., 4(2) 1995, pp. 124-137.
Ledford, Dennis K., “Alternative Treatments for Severe, Chronic Asthma”,Allergy Proc., Jan.-Feb. 1993, vol. 14, No. 1, pp. 23-30.
Ledford, Dennis K., “Treatment of Steroid-Resistant Asthma”,Immunology and Allergy Clinics of North America, vol. 16, No. 4, Nov. 1996, pp. 777-796.
Moss, Richard B., “Alternative Pharmacotherapies for Steroid-Dependent Asthma”,Chest, vol. 107, No. 3, Mar. 1995, pp. 817-825.
Ornstein, Matthew H., et al., “The Anti-Inflammatory and Antiviral Effects of Hydroxy-Chloroquine (HCQ) in 2 Patients with Aids and Active Inflammatory Arthritis”,Arthritis&Rheumatism, vol. 38, No. 9, p. S198, 1995.
Roberts, J.A., et al., “Effect of Hydroxychloroquine in Chronic Steroid Dependent Asthma”,J. Allergy Clin. Immune, 1986, vol. 77, No. 1, Part 2, p. 151.
Roberts, J.A., et al., “Hydroxychloroquine in Steroid Dependent Asthma”,Pulmonary Pharmacology, 1998, p. 59-61.
Seggey, J.S., et al., “Inhibition of IL-4-Driven IgE Synthesis by Peripheral Blood Lymphocytes (PBL) in vitro with Hydroxychloroquine (HCQ)”,Allergic Disease IgE, No. 343, p. 62A, 1993.
Sherman, et al., “Short-Term Effects of Hydroxychloroquine (HCQ) on IgE Levels and Obstructive Airways Disease”,J. Allergy Clin. Immunol., Jan. 1992, No. 567, p. 286.
Sorkness, Christine, et al., “Alternatives to Corticosteroids in the Treatment of Asthma”,Immunology and Allergy Clinics of North America, vol. 13, No. 4, Nov. 1993, p. 917-938.
Letter dated Nov. 30, 1998, in Response to Written Opinion in PCT International Publication No. WO 98/17231.
APT Pharmaceuticals, LLC
Navarro Mark
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Uses for anti-malarial therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses for anti-malarial therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for anti-malarial therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3810494